Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZBIO · against 426 other Healthcare companies of similar size
Ranked #93 of 427 · scores higher than 78% of peers · safety percentile 79
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)45 peers with a safety percentile of 70–79, including ZBIO · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ZBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 404 reported | 1.21× | 0.23× | 13% | 33% | |
| BetaLower is better · 400 reported | -1.02 | 0.53 | 99% | 33% | |
| Current ratioHigher is better · 412 reported | 9.93× | 2.78× | 86% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 89 | 143.3B JPY (≈$975M) | 81 | 61 | |
| 90 | 142.5B INR (≈$1.7B) | 80 | 71 | |
| 91 | 1.1B USD | 80 | 61 | |
| 92 | 8.9B CNY (≈$1.2B) | 80 | 62 | |
| 93 | 1.8B USD | 79 | 23 | |
| 94 | 1.7B USD | 79 | 30 | |
| 95 | 10.9B CNY (≈$1.5B) | 79 | 72 | |
| 96 | 2.3B USD | 79 | 74 | |
| 97 | 18.3B DKK (≈$2.7B) | 79 | 81 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score